Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610349767> ?p ?o ?g. }
- W2610349767 endingPage "52912" @default.
- W2610349767 startingPage "52901" @default.
- W2610349767 abstract "// Yan-Rong Liu 1, * , Lan Liang 3, * , Jian Min Zhao 4, * , Yang Zhang 5, * , Min Zhang 1, 2 , Wei-Long Zhong 1, 2 , Qiang Zhang 1, 2 , Jun-Jie Wei 1, 2 , Meng Li 1, 2 , Jie Yuan 1, 2 , Shuang Chen 1 , Shu-Min Zong 1, 2 , Hui-Juan Liu 1 , Jing Meng 1, 2 , Yuan Qin 1, 2 , Bo Sun 1 , Lan Yang 1 , Hong-Gang Zhou 1, 2 , Tao Sun 1, 2 and Cheng Yang 1, 2 1 Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China 2 State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China 3 Tianjin GoalGen Biotechnology Co., Ltd., Tianjin, China 4 Pathology Department, Shun Yi District Hospital, Beijing, China 5 Department of Anesthesiology, Tianjin 4th Center Hospital, Tianjin, China * These authors have contributed equally to this work Correspondence to: Cheng Yang, email: cheng.yang@nankai.edu.cn Tao Sun, email: sunrockmia@hotmail.com Keywords: Twist1, multidrug resistance, colon cancer, ABCB1, ABCC1 Received: December 29, 2016 Accepted: March 30, 2017 Published: May 02, 2017 ABSTRACT Multidrug resistance is a major problem in colon cancer treatment. However, its molecular mechanisms remain unclear. Recently, the epithelial-mesenchymal transition (EMT) in anticancer drug resistance has attracted increasing attention. This study investigated whether vincristine treatment induces EMT and promotes multidrug resistance in colon cancer. The result showed that vincristine treatment increases the expression of several ATP-binding cassette transporters in invasive human colon adenocarcinoma cell line (HCT-8). Vincristine-resistant HCT-8 cells (HCT-8/V) acquire a mesenchymal phenotype, and thus its migratory and invasive ability are increased both in vitro and in vivo . The master transcriptional factors of EMT, especially Twist1, were significantly increased in the HCT-8/V cell line. Moreover, the ectopic expression of Twist1 increased the chemoresistance of HCT-8 cells to vincristine and increased the expression levels and promoter activities of ABCB1 and ABCC1. Furthermore, Twist1 silencing reverses the EMT phenotype, enhances the chemosensitivity of HCT-8/ V cells to anticancer agents in vitro and in vivo , and downregulates the expression of ABCB1 and ABCC1. Twist1-mediated promotion of ABCB1 and ABCC1 expression levels plays an important role in the drug resistance of colon cancer cells." @default.
- W2610349767 created "2017-05-12" @default.
- W2610349767 creator A5013811376 @default.
- W2610349767 creator A5017379979 @default.
- W2610349767 creator A5019075050 @default.
- W2610349767 creator A5022802322 @default.
- W2610349767 creator A5023746991 @default.
- W2610349767 creator A5034916569 @default.
- W2610349767 creator A5037377007 @default.
- W2610349767 creator A5039837606 @default.
- W2610349767 creator A5041756956 @default.
- W2610349767 creator A5046542455 @default.
- W2610349767 creator A5059914871 @default.
- W2610349767 creator A5061927010 @default.
- W2610349767 creator A5062277357 @default.
- W2610349767 creator A5065748896 @default.
- W2610349767 creator A5066953740 @default.
- W2610349767 creator A5070492885 @default.
- W2610349767 creator A5078024000 @default.
- W2610349767 creator A5080449639 @default.
- W2610349767 creator A5085610505 @default.
- W2610349767 creator A5090932841 @default.
- W2610349767 date "2017-05-02" @default.
- W2610349767 modified "2023-09-28" @default.
- W2610349767 title "Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters" @default.
- W2610349767 cites W147439079 @default.
- W2610349767 cites W1518708967 @default.
- W2610349767 cites W1553345136 @default.
- W2610349767 cites W1572770561 @default.
- W2610349767 cites W1964767165 @default.
- W2610349767 cites W1981140460 @default.
- W2610349767 cites W2042167978 @default.
- W2610349767 cites W2051511388 @default.
- W2610349767 cites W2059491046 @default.
- W2610349767 cites W2063011414 @default.
- W2610349767 cites W2083798214 @default.
- W2610349767 cites W2086702949 @default.
- W2610349767 cites W2136615032 @default.
- W2610349767 cites W2254952302 @default.
- W2610349767 cites W2326919835 @default.
- W2610349767 cites W2414671644 @default.
- W2610349767 cites W2554936259 @default.
- W2610349767 doi "https://doi.org/10.18632/oncotarget.17548" @default.
- W2610349767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5581080" @default.
- W2610349767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28881781" @default.
- W2610349767 hasPublicationYear "2017" @default.
- W2610349767 type Work @default.
- W2610349767 sameAs 2610349767 @default.
- W2610349767 citedByCount "20" @default.
- W2610349767 countsByYear W26103497672017 @default.
- W2610349767 countsByYear W26103497672018 @default.
- W2610349767 countsByYear W26103497672019 @default.
- W2610349767 countsByYear W26103497672020 @default.
- W2610349767 countsByYear W26103497672021 @default.
- W2610349767 countsByYear W26103497672022 @default.
- W2610349767 countsByYear W26103497672023 @default.
- W2610349767 crossrefType "journal-article" @default.
- W2610349767 hasAuthorship W2610349767A5013811376 @default.
- W2610349767 hasAuthorship W2610349767A5017379979 @default.
- W2610349767 hasAuthorship W2610349767A5019075050 @default.
- W2610349767 hasAuthorship W2610349767A5022802322 @default.
- W2610349767 hasAuthorship W2610349767A5023746991 @default.
- W2610349767 hasAuthorship W2610349767A5034916569 @default.
- W2610349767 hasAuthorship W2610349767A5037377007 @default.
- W2610349767 hasAuthorship W2610349767A5039837606 @default.
- W2610349767 hasAuthorship W2610349767A5041756956 @default.
- W2610349767 hasAuthorship W2610349767A5046542455 @default.
- W2610349767 hasAuthorship W2610349767A5059914871 @default.
- W2610349767 hasAuthorship W2610349767A5061927010 @default.
- W2610349767 hasAuthorship W2610349767A5062277357 @default.
- W2610349767 hasAuthorship W2610349767A5065748896 @default.
- W2610349767 hasAuthorship W2610349767A5066953740 @default.
- W2610349767 hasAuthorship W2610349767A5070492885 @default.
- W2610349767 hasAuthorship W2610349767A5078024000 @default.
- W2610349767 hasAuthorship W2610349767A5080449639 @default.
- W2610349767 hasAuthorship W2610349767A5085610505 @default.
- W2610349767 hasAuthorship W2610349767A5090932841 @default.
- W2610349767 hasBestOaLocation W26103497671 @default.
- W2610349767 hasConcept C104317684 @default.
- W2610349767 hasConcept C114851261 @default.
- W2610349767 hasConcept C121608353 @default.
- W2610349767 hasConcept C126322002 @default.
- W2610349767 hasConcept C133936738 @default.
- W2610349767 hasConcept C143998085 @default.
- W2610349767 hasConcept C149011108 @default.
- W2610349767 hasConcept C2779013556 @default.
- W2610349767 hasConcept C44312359 @default.
- W2610349767 hasConcept C502942594 @default.
- W2610349767 hasConcept C54355233 @default.
- W2610349767 hasConcept C71924100 @default.
- W2610349767 hasConcept C76419328 @default.
- W2610349767 hasConcept C86803240 @default.
- W2610349767 hasConceptScore W2610349767C104317684 @default.
- W2610349767 hasConceptScore W2610349767C114851261 @default.
- W2610349767 hasConceptScore W2610349767C121608353 @default.
- W2610349767 hasConceptScore W2610349767C126322002 @default.
- W2610349767 hasConceptScore W2610349767C133936738 @default.
- W2610349767 hasConceptScore W2610349767C143998085 @default.